United States · FDA National Drug Code directory
Sulindac
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0591-5660_988f11c7-805d-4926-84b3-4c9c0cb0038d
- Product NDC
- 0591-5660
- Form
- TABLET
- Composition / generic term
- Sulindac
- Labeler
- Actavis Pharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19900403
- Source listing expiry
- 20261231
Source-listed ingredients
- SULINDAC — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (0591-5660-01) · 0591-5660-01
- 500 TABLET in 1 BOTTLE, PLASTIC (0591-5660-05) · 0591-5660-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →